1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HNRNPU CTRPv2 pan-cancer AAC 0.22 1e-10
mRNA SAFB CTRPv2 pan-cancer AAC 0.24 1e-10
mRNA CDK19 CTRPv2 pan-cancer AAC 0.22 1e-10
mRNA SBK1 CTRPv2 pan-cancer AAC 0.22 1e-10
mRNA RNF181 CTRPv2 pan-cancer AAC -0.21 1e-10
mRNA SLFN11 CTRPv2 pan-cancer AAC 0.22 1e-10
mRNA CNIH2 CTRPv2 pan-cancer AAC 0.22 2e-10
mRNA H3F3A CTRPv2 pan-cancer AAC 0.22 2e-10
mRNA TMPO CTRPv2 pan-cancer AAC 0.22 2e-10
mRNA ZNF713 CTRPv2 pan-cancer AAC 0.21 2e-10
Download CSV